ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $50,000 | -10.7% | 18,775 | 0.0% | 0.00% | – |
| Q1 2019 | $56,000 | +86.7% | 18,775 | 0.0% | 0.00% | – |
| Q4 2018 | $30,000 | -56.5% | 18,775 | 0.0% | 0.00% | – |
| Q3 2018 | $69,000 | +30.2% | 18,775 | 0.0% | 0.00% | – |
| Q2 2018 | $53,000 | -24.3% | 18,775 | 0.0% | 0.00% | – |
| Q1 2018 | $70,000 | -90.2% | 18,775 | -81.9% | 0.00% | -100.0% |
| Q3 2015 | $717,000 | -25.5% | 103,710 | -4.6% | 0.00% | 0.0% |
| Q2 2015 | $963,000 | -8.1% | 108,740 | +2.3% | 0.00% | -25.0% |
| Q1 2015 | $1,048,000 | +516.5% | 106,260 | +664.5% | 0.00% | +300.0% |
| Q4 2014 | $170,000 | – | 13,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |